Fig. 1From: Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancerThe Kaplan-Meier estimates indicate overall survival (a) and relapse-free survival (b) after curative gastrectomy for stage III gastric cancerBack to article page